BLT 0.00% 2.6¢ benitec biopharma limited

Two words: Track Record It seems that no one with money will...

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    Two words: Track Record

    It seems that no one with money will sponsor a program of ours until we prove it is efficacious in humans. I have said many times that we need a pre-clinical deal, but I am afraid that seems less likely than ever because, no matter how much good pre-clinical data we produce, the share price stays in the doldrums.

    Let's hope that either the CoH or the Calimmune results go some way to convincing pharma that ddRNAi works and has a place in the treatment of human indications. Roll on August.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.